Skip to content
Advertisement

This undated image provided by Merck on Friday, Oct. 5, 2018 shows a vial and packaging for the Gardasil 9 vaccine. On Friday, Oct. 5, 2018, the U.S. Food and Drug Administration expanded the use of the company's cervical cancer vaccine to adults up to age 45. (Merck via AP)

This undated image provided by Merck on Friday, Oct. 5, 2018 shows a vial and packaging for the Gardasil 9 vaccine. On Friday, Oct. 5, 2018, the U.S. Food and Drug Administration expanded the use of the company's cervical cancer vaccine to adults up to age 45. (Merck via AP)

Featured Photo Galleries